Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Frasers ups stake in Hugo Boss

(Sharecast News) - Mike Ashley's acquisitive Frasers Group has further upped its stake in German fashion brand Hugo Boss. In a statement released after markets had closed on Wednesday, Frasers said it had sold a number of put options in the Frankfurt-listed business.

As a result, it now owns 13.5m shares, or 19.2% of the total share capital, and up to 16.7m shares through put options, representing 23.7% of the total share capital.

The company said it now had a maximum aggregate exposure in connection to Hugo Boss of around €1.02bn.

If all the put options were exercised, it would take Frasers' stake to a significant 42.9%.

However, the British retailer looked to rule out any desire to take full control of the business, noting: "The company remains a long term investor in Hugo Boss, and the board of directors...believes that the Hugo Boss strategic investment will create value for shareholders, as [it has] done in the past."

Frasers, which owns Sports Direct, Evans Cycles and Everlast, among others, first invested in the brand in 2020 by taking a 5.1% stake.

Chief executive Michael Murray - Ashley's son-in-law - is seeking election to Hugo Boss's supervisory board at May's annual shareholder meeting.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.